EUVIMEDEUVIMED entdecken
Open Access

Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs

Lakshmi Balagopalan iD, Taylor Moreno iD, Haiying Qin iD, Benjamin C Angeles iD, Taisuke Kondo iD, Jason Yi, Katherine M McIntire, Neriah Alvinez iD, Sandeep Pallikkuth, Mariah E Lee iD, Hidehiro Yamane, Andy D Tran iD und 4 weitere

Science Signaling · 23.07.2024 · 17 (846)

DOI: 10.1126/scisignal.adp8569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, erschienen am 23.07.2024. Verfasst von Lakshmi Balagopalan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2089…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Signal Transduction, Receptors, Antigen, T-Cell, T-Lymphocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T cells have been used to successfully treat various blood cancers, but adverse effects have limited their potential. Here, we developed chimeric adaptor proteins (CAPs) and CAR tyrosine kinases (CAR-TKs) in which the intracellular ζ T cell receptor (TCRζ) chain was replaced with intracellular protein domains to stimulate signaling downstream of the TCRζ chain. CAPs contain adaptor domains and the kinase domain of ZAP70, whereas CAR-TKs contain only ZAP70 domains. We hypothesized that CAPs and CAR-TKs would be more potent than CARs because they would bypass both the steps that define the signaling threshold of TCRζ and the inhibitory regulation of upstream molecules. CAPs were too potent and exhibited high tonic signaling in vitro. In contrast, CAR-TKs exhibited high antitumor efficacy and significantly enhanced long-term tumor clearance in leukemia-bearing NSG mice as compared with the conventional CD19-28ζ-CAR-T cells. CAR-TKs were activated in a manner independent of the kinase Lck and displayed slower phosphorylation kinetics and prolonged signaling compared with the 28ζ-CAR. Lck inhibition attenuated CAR-TK cell exhaustion and improved long-term function. The distinct signaling properties of CAR-TKs may therefore be harnessed to improve the in vivo efficacy of T cells engineered to express an antitumor chimeric receptor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenSignal TransductionReceptors, Antigen, T-CellT-LymphocytesAnimalsHumansMiceZAP-70 Protein-Tyrosine KinaseImmunotherapy, AdoptiveMice, Inbred NODCell Line, TumorPhosphorylation

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-CellZAP-70 Protein-Tyrosine Kinase

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
  • Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Laboratory of Cancer Biology and Genetics (CCR Microscopy Core), National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Integrated Data Science Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

ORCID-Profile: Lakshmi Balagopalan, Taylor Moreno, Haiying Qin, Benjamin C Angeles, Taisuke Kondo, Neriah Alvinez, Mariah E Lee, Andy D Tran, Philippe Youkharibache, Raul E Cachau, Naomi Taylor, Lawrence E Samelson

Förderung

  • Intramural NIH HHS

Zitieren

APA

Balagopalan, L., Moreno, T., Qin, H., Angeles, B. C., Kondo, T., Yi, J., McIntire, K. M., Alvinez, N., Pallikkuth, S., Lee, M. E., Yamane, H., Tran, A. D., Youkharibache, P., Cachau, R. E., Taylor, N., & Samelson, L. E. (2024). Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs. Science Signaling, 17(846). https://doi.org/10.1126/scisignal.adp8569

Vancouver

Balagopalan L, Moreno T, Qin H, Angeles BC, Kondo T, Yi J, et al. Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs. Science Signaling. 2024;17(846). doi:10.1126/scisignal.adp8569

BibTeX
@article{Balagopalan2024,
  author = {Balagopalan, Lakshmi and Moreno, Taylor and Qin, Haiying and Angeles, Benjamin C and Kondo, Taisuke and Yi, Jason and McIntire, Katherine M and Alvinez, Neriah and Pallikkuth, Sandeep and Lee, Mariah E and Yamane, Hidehiro and Tran, Andy D and Youkharibache, Philippe and Cachau, Raul E and Taylor, Naomi and Samelson, Lawrence E},
  title = {Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs},
  journal = {Science Signaling},
  year = {2024},
  volume = {17},
  number = {846},
  doi = {10.1126/scisignal.adp8569}
}
Kostenlos starten →